Exploring the nicotinic acetylcholine receptor-associated proteome with iTRAQ and transgenic mice

Area of Science:

• Neuroscience
• Molecular Biology
• Pharmacology

Background:

• Neuronal nicotinic acetylcholine receptors (nAChRs) with α4 and β2 subunits (α4β2*) are key in the central nervous system, binding nicotine with high affinity.
• These receptors play critical roles in nicotine dependence, mood disorders, and neuroprotection/neurodegeneration.
• The protein interactions of α4β2* nAChRs are not well understood.

Purpose of the Study:

• To identify proteins that interact with α4β2* nAChRs.
• To investigate gene-dose dependent interactions.
• To discover potential targets for pharmacological intervention.

Main Methods:

• Quantitative proteomics using isobaric tags for relative and absolute quantitation (iTRAQ).
• Immunopurification of β2* nAChRs from mice with varying α4 and β2 subunit expression.
• Stratified linear regression analysis to identify correlated protein levels.

Main Results:

• Identified 208 proteins co-immunoprecipitated with α4β2* nAChRs.
• Found that reduced expression of α4 or β2 subunits correlated with decreased expression of interacting proteins.
• Identified 17 proteins significantly correlated with α4β2* nAChR expression, including those in cytoskeletal rearrangement and calcium signaling pathways.

Conclusions:

• This study presents the first quantitative proteomic analysis of the β2* nAChR interactome.
• The findings provide novel insights into the molecular interactions of α4β2* nAChRs.
• This work establishes a new technique for discovering pharmacological targets for modulating α4β2* nAChR function and downstream signaling.